Comparison of Mismatch Amplification Mutation Assay with DNA Sequencing for Characterization of Fluoroquinolone Resistance in Neisseria gonorrhoeae

Journal of Clinical Microbiology

Volumn 42, Issue 2, 2004, Pages 591-594

  Sultan, Zafar ^a   Nahar, Shamsun ^a   Wretlind, Bengt ^b   Lindback, Emma ^b   Rahman, Motiur ^a,c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GLYCINE; QUINOLONE DERIVATIVE; SERINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BASE MISPAIRING; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; COST; DNA SEQUENCE; GENE AMPLIFICATION; GYRA GENE; MINIMUM INHIBITORY CONCENTRATION; MISMATCH AMPLIFICATION MUTATION ASSAY; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; NEISSERIA; NEISSERIA GONORRHOEAE;

EID: 1242336865     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.2.591-594.2004     Document Type: Article

References (24)

1. Belland, R. J., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
2. Centers for Disease Control and Prevention. 2002. Sexually transmitted diseases treatment guidelines 2002. Morb. Mortal. Wkly. Rep. 51:1-80.
3. Charvalos, E., E. Peteinaki, I. Spyridaki, S. Manetas, and Y. Tselentis. 1996. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing. J. Clin. Lab Anal. 10:129-133.
4. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, S. Maeda, I. Saito, and Y. Kawada. 1996. Rapid detection of point mutations of the Neisseria gonotrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J. Clin. Microbiol. 34:2255-2258.
5. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, I. Saito, and Y. Kawada. 1996. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob. Agents Chemother. 40:1020-1023.
6. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Kawada, T. Ezaki, and I. Saito. 1996. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 40:2437-2438.
7. Drlica, K., and X. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
8. el Amin, N. A., S. Jalal, and B. Wretlind. 1999. Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 43:947-949.
9. Fiorito, S., P. Galarza, I. Pagano, C. Oviedo, A. Lanza, J. Smayevsky, G. Weltman, L. Buscemi, and E. Sanjuan. 2001. Emergence of high level ciprofloxacin resistant Neisseria gonorrhoeae strain in Buenos Aires, Argentina. Sex. Transm. Infect. 77:77.
10. Ivens, D., I. Martin, and C. Ison. 2000. Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a first-line therapy? Int. J. STD AIDS 11:774-776.
11. Jalal, S., and B. Wretlind. 1998. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb. Drug Resist. 4:257-261.
12. Lindback, E., M. Rahman, S. Jalal, and B. Wretlind. 2002. Mutations in gyrA, gyrB, parE, and pare in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 110:651-657.
13. Llanes, R., J. Sosa, D. Guzman, Y. Gutierrez, A. Llop, and O. Ricardo. 2001. Neisseria gonorrhoeae resistant to ciprofloxacin: first report in Cuba. Sex. Transm. Dis. 28:82-83.
14. National Committee for Clinical Laboratory Standards. 1993. Approved standards M7-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial susceptibility testing 14. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Oppegaard, H., and H. Sorum. 1994. gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida. Antimicrob. Agents Chemother. 38:2460-2464.
17. Oram, M., and L. M. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35:387-389.
18. Otero, L., B. Alcala, J. A. Varela, M. D. Miguel, J. A. Vazquez, and F. Vazquez. 2001. First isolate of a Neisseria gonorrhoeae strain associated with an ofloxacin treatment failure in Spain: case report. Sex. Transm. Dis. 28: 576-578.
19. Rahman, M., G. Mauff, J. Levy, M. Couturier, G. Pulverer, N. Glasdorff, and J. P. Butzler. 1994. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob. Agents Chemother. 38:2488-2491.
20. Rahman, M., Z. Sultan, S. Monira, A. Alam, K. Nessa, S. Islam, S. Nahar, A. W. Shama, S. Alam Khan, J. Bogaerts, N. Islam, and J. Albert. 2002. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance. J. Clin. Microbiol. 40:2037-2040.
21. Reyna, F., M. Huesca, V. Gonzalez, and L. Y. Fuchs. 1995. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 39:1621-1623.
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Tanaka, M., H. Nakayama, M. Haraoka, and T. Saika. 2000. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. J. Clin. Microbiol. 38:521-525.
24. Zirnstein, G., Y. Li, B. Swaminathan, and F. Angulo. 1999. Ciprofloxacin resistance in Campylobacterjejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. J. Clin. Microbiol. 37:3276-3280.